Lakewood-Amedex Biotherapeutics Inc. (LABT)

NASDAQ

$0.31

$-0.18

(-35.87%)

Previous Close: ⁦$0.49⁩

Market Closed

Lakewood-Amedex Biotherapeutics Inc. (LABT) Live Price Chart

Last updated: ⁦2026-10-24 19:24:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Lakewood-Amedex Biotherapeutics Inc. (LABT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.31, with a market capitalization of $1.16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.28 to $98.20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.16M
Open	$0.35
Day's High	$98.20
Day's Low	$0.28
Previous Close	$0.49
Volume	38.28M
Average Volume	1.87M
P/E Ratio	--
52-Week High	$98.20
52-Week Low	$0.28
Dividend Yield	--
Earnings Date	--

Lakewood-Amedex Biotherapeutics Inc. (LABT) Latest Closing Stock Price

Lakewood-Amedex Biotherapeutics Inc. (LABT) last closed at $0.49 as of 2026-10-24 00:00:00, unchanged from the previous close of $0.49.

During the latest regular trading session, LABT traded between $0.28 and $98.20, with a volume of 38.28M shares. The closing price was near the lower end and near the lower end of its 52-week range.

Lakewood-Amedex Biotherapeutics Inc. (LABT) 7-Day Stock Price Change

Over the past seven days, Lakewood-Amedex Biotherapeutics Inc. (LABT) moved from $0.61 to $0.31, representing a decline of 48.89% ($0.30).

The stock traded between $0.28 and $1.05 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 5.92 million shares, up versus the previous seven-day period, indicating higher trading activity.

LABT 52-Week Price Position

Position in Range: 0.0%

52W Low$0.28

52W High$98.20

LABT is currently trading at $0.31, placing it 0.0% of the way from its 52-week low of $0.28 to its 52-week high of $98.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)?

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Lakewood-Amedex Biotherapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://lakewoodamedex.com

How to Buy Lakewood-Amedex Biotherapeutics Inc. (LABT) Stock on MEXC

Eligible investors can buy real shares of Lakewood-Amedex Biotherapeutics Inc. (LABT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LABT and Place Your Order

Open the RealStocks trading page and search for LABT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lakewood-Amedex Biotherapeutics Inc. (LABT) stock price today?

Lakewood-Amedex Biotherapeutics Inc. (LABT) is currently trading at $ 0.31, down 36.06% ($0.18) from the previous close of $ 0.49. Intraday prices update in real time during regular trading hours.

2.Is LABT stock going up or down today?

As of 2026-10-24 00:00:00, LABT is trading at $ 0.31, down 36.06% ($0.18) from its previous close of $ 0.49. The stock has traded between $ 0.28 and $ 98.20 during today’s regular session. Past price movements do not guarantee future results.

3.What is LABT pre-market price?

As of 2026-10-24 00:00:00, LABT is trading at $ 0.34 in pre-market trading, down 29.93% ($0.15) from the previous close of $ 0.49. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LABT after-hours price?

As of 2026-10-24 00:00:00, LABT is trading at $ 0.26 in after-hours trading, down 46.48% ($0.23) from the regular-session close of $ 0.49. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LABT stock trading now?

LABT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LABT sit relative to its 52-week high and low?

Over the past 52 weeks, LABT has traded between a low of $ 0.28 and a high of $ 98.20. At $ 0.31, the stock is positioned 0.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lakewood-Amedex Biotherapeutics Inc. in?

Lakewood-Amedex Biotherapeutics Inc. (LABT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lakewood-Amedex Biotherapeutics Inc.'s market capitalization and where is it listed?

Lakewood-Amedex Biotherapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.16M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LABT valued in terms of P/E ratio and EPS?

LABT trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lakewood-Amedex Biotherapeutics Inc. pay a dividend?

Lakewood-Amedex Biotherapeutics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.